CMFRI's natural product from seaweeds to combat fatty liver disease to hit market soon

CMFRI, Library (2022) CMFRI's natural product from seaweeds to combat fatty liver disease to hit market soon. Aquaculture Spectrum, 5 (12). p. 66. ISSN 2581-7892

Text Aquaculture Spectrum_2022_Natural Product.pdf Download (65kB)

Abstract

CadalminTM LivCure extract, a patent-protected nutraceutical product developed by the ICARCentral Marine Fisheries Research Institute (CMFRI) from seaweeds to combat non-alcoholic fatty liver disease (NAFLD) will hit the markets soon. CMFRI signed a Memorandum of Understanding (MoU) with M/s. Emineotech, a private limited company dealing with health products, for commercial production and marketing. Dr. A. Gopalakrishnan, Director of CMFRI signed a license agreement with Mr. Evanjalist Pathrose, Managing Director of Emineotech.

Actions (login required)

View Item